These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17073793)

  • 1. Biocatalytic conversion of avermectin into 4''-oxo-avermectin: discovery, characterization, heterologous expression and specificity improvement of the cytochrome P450 enzyme.
    Molnár I; Jungmann V; Stege J; Trefzer A; Pachlatko JP
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1236-40. PubMed ID: 17073793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocatalytic conversion of avermectin to 4"-oxo-avermectin: characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes.
    Jungmann V; Molnár I; Hammer PE; Hill DS; Zirkle R; Buckel TG; Buckel D; Ligon JM; Pachlatko JP
    Appl Environ Microbiol; 2005 Nov; 71(11):6968-76. PubMed ID: 16269732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocatalytic conversion of avermectin to 4''-oxo-avermectin: improvement of cytochrome p450 monooxygenase specificity by directed evolution.
    Trefzer A; Jungmann V; Molnár I; Botejue A; Buckel D; Frey G; Hill DS; Jörg M; Ligon JM; Mason D; Moore D; Pachlatko JP; Richardson TH; Spangenberg P; Wall MA; Zirkle R; Stege JT
    Appl Environ Microbiol; 2007 Jul; 73(13):4317-25. PubMed ID: 17483257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalytic conversion of avermectin to 4"-oxo-avermectin: heterologous expression of the ema1 cytochrome P450 monooxygenase.
    Molnár I; Hill DS; Zirkle R; Hammer PE; Gross F; Buckel TG; Jungmann V; Pachlatko JP; Ligon JM
    Appl Environ Microbiol; 2005 Nov; 71(11):6977-85. PubMed ID: 16269733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CYP107Z13 in Streptomyces lividans TK54 catalyzes the oxidation of avermectin to 4″-oxo-avermectin.
    Jiang X; Liu W; Ji Y; Niu J; Li M
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1957-63. PubMed ID: 21842154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the electron transfer pathway in the oxidation of avermectin by CYP107Z13 in Streptomyces ahygroscopicus ZB01.
    Li M; Zhang Y; Zhang L; Yang X; Jiang X
    PLoS One; 2014; 9(6):e98916. PubMed ID: 24905717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding electron transport systems of Streptomyces cytochrome P450.
    Chun YJ; Shimada T; Waterman MR; Guengerich FP
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1183-5. PubMed ID: 17073781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome analyses of Streptomyces peucetius ATCC 27952 for the identification and comparison of cytochrome P450 complement with other Streptomyces.
    Parajuli N; Basnet DB; Chan Lee H; Sohng JK; Liou K
    Arch Biochem Biophys; 2004 May; 425(2):233-41. PubMed ID: 15111132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative activities of heterologously expressed CYP107B1 and CYP105D1 in whole-cell biotransformation using Streptomyces lividans TK24.
    Ueno M; Yamashita M; Hashimoto M; Hino M; Fujie A
    J Biosci Bioeng; 2005 Nov; 100(5):567-72. PubMed ID: 16384798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing a whole-cell biotransformation system in Escherichia coli using cytochrome P450 from Streptomyces peucetius.
    Shrestha P; Oh TJ; Sohng JK
    Biotechnol Lett; 2008 Jun; 30(6):1101-6. PubMed ID: 18259876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome p450 complement (CYPome) of the avermectin-producer Streptomyces avermitilis and comparison to that of Streptomyces coelicolor A3(2).
    Lamb DC; Ikeda H; Nelson DR; Ishikawa J; Skaug T; Jackson C; Omura S; Waterman MR; Kelly SL
    Biochem Biophys Res Commun; 2003 Aug; 307(3):610-9. PubMed ID: 12893267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of avermectin-high-producing strains by high-throughput screening methods.
    Gao H; Liu M; Zhou X; Liu J; Zhuo Y; Gou Z; Xu B; Zhang W; Liu X; Luo A; Zheng C; Chen X; Zhang L
    Appl Microbiol Biotechnol; 2010 Jan; 85(4):1219-25. PubMed ID: 19957083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a regulatory gene, aveR, for the biosynthesis of avermectin in Streptomyces avermitilis.
    Kitani S; Ikeda H; Sakamoto T; Noguchi S; Nihira T
    Appl Microbiol Biotechnol; 2009 Apr; 82(6):1089-96. PubMed ID: 19148632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative transcriptome analysis for avermectin overproduction via Streptomyces avermitilis microarray system.
    Im JH; Kim MG; Kim ES
    J Microbiol Biotechnol; 2007 Mar; 17(3):534-8. PubMed ID: 18050961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spectrophotometric screening method for avermectin oxidizing microorganisms.
    Wang YS; Hu QW; Zheng XC; Zhang JF; Zheng YG
    J Microbiol Methods; 2017 Apr; 135():93-95. PubMed ID: 28215961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P450(BM-3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system.
    Schewe H; Holtmann D; Schrader J
    Appl Microbiol Biotechnol; 2009 Jul; 83(5):849-57. PubMed ID: 19266193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation.
    Joo H; Lin Z; Arnold FH
    Nature; 1999 Jun; 399(6737):670-3. PubMed ID: 10385118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 enzymes from the bacterium Novosphingobium aromaticivorans.
    Bell SG; Wong LL
    Biochem Biophys Res Commun; 2007 Aug; 360(3):666-72. PubMed ID: 17618912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, expression, and characterization of a self-sufficient cytochrome P450 monooxygenase from Rhodococcus ruber DSM 44319.
    Liu L; Schmid RD; Urlacher VB
    Appl Microbiol Biotechnol; 2006 Oct; 72(5):876-82. PubMed ID: 16607529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium optimization for the production of avermectin B1a by Streptomyces avermitilis 14-12A using response surface methodology.
    Gao H; Liu M; Liu J; Dai H; Zhou X; Liu X; Zhuo Y; Zhang W; Zhang L
    Bioresour Technol; 2009 Sep; 100(17):4012-6. PubMed ID: 19356927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.